北方药学
北方藥學
북방약학
JOURNAL OF NORTH PHARMACY
2015年
5期
141-142
,共2页
甲氨蝶呤%柳氮磺吡啶%非甾体抗炎药%类风湿性关节炎
甲氨蝶呤%柳氮磺吡啶%非甾體抗炎藥%類風濕性關節炎
갑안접령%류담광필정%비치체항염약%류풍습성관절염
methotrexate%Sulfasalazine%Non-steroidal anti-inflammatory drug%Rheumatoid arthritis
目的:对比甲氨蝶呤联合柳氮磺吡啶与非甾体类抗炎药治疗类风湿性关节炎的疗效。方法:选择2011年4月~2013年9月在我院就诊的类风湿性关节炎患者共50例,采用随机方式将其分为观察组和对照组,观察组给予甲氨蝶呤联合柳氮磺吡啶进行治疗,对照组则使用非甾体类抗炎药。治疗1年后,记录两组疗效以及不良反应情况。结果:观察组治疗的总有效率明显高于对照组,差异具有统计学意义(u=3.8314,P=0.0001),且观察组患者的各项指标明显优于治疗前,相比差异有统计学意义(P<0.05)。观察组不良反应总发生率明显低于对照组,差异有统计学意义(P<0.05)。结论:与非甾体类抗炎药相比,使用甲氨蝶呤联合柳氮磺吡啶治疗类风湿性关节炎的疗效更为显著。
目的:對比甲氨蝶呤聯閤柳氮磺吡啶與非甾體類抗炎藥治療類風濕性關節炎的療效。方法:選擇2011年4月~2013年9月在我院就診的類風濕性關節炎患者共50例,採用隨機方式將其分為觀察組和對照組,觀察組給予甲氨蝶呤聯閤柳氮磺吡啶進行治療,對照組則使用非甾體類抗炎藥。治療1年後,記錄兩組療效以及不良反應情況。結果:觀察組治療的總有效率明顯高于對照組,差異具有統計學意義(u=3.8314,P=0.0001),且觀察組患者的各項指標明顯優于治療前,相比差異有統計學意義(P<0.05)。觀察組不良反應總髮生率明顯低于對照組,差異有統計學意義(P<0.05)。結論:與非甾體類抗炎藥相比,使用甲氨蝶呤聯閤柳氮磺吡啶治療類風濕性關節炎的療效更為顯著。
목적:대비갑안접령연합류담광필정여비치체류항염약치료류풍습성관절염적료효。방법:선택2011년4월~2013년9월재아원취진적류풍습성관절염환자공50례,채용수궤방식장기분위관찰조화대조조,관찰조급여갑안접령연합류담광필정진행치료,대조조칙사용비치체류항염약。치료1년후,기록량조료효이급불량반응정황。결과:관찰조치료적총유효솔명현고우대조조,차이구유통계학의의(u=3.8314,P=0.0001),차관찰조환자적각항지표명현우우치료전,상비차이유통계학의의(P<0.05)。관찰조불량반응총발생솔명현저우대조조,차이유통계학의의(P<0.05)。결론:여비치체류항염약상비,사용갑안접령연합류담광필정치료류풍습성관절염적료효경위현저。
Objective: To compare the efficacy of methotrexate and sulfasalazine treatment of rheumatoid and non-steroidal anti-inflammatory drugs. Methods:Patients with rheumatoid arthritis disease from April 2011 to September 2013 in our hospital a total of 50 patients were randomly divided into observation mode and control groups, given the observation group were using armor ammonia Combined methotrexate sulfasalazine treatment, the control group of patients is the use of non-steroidal anti-inflammatory drugs. After 1 year of treatment, therapy and case records of adverse reactions occurred in both groups of patients. Results: After treatment, patients in the observation group total effective rate was significantly higher, the difference was statistically significant compared to (u=3.8314, P=0.0001), the indicators and the observation group were significantly better than before treatment, compared with statistically significant differences (P<0.05). Adverse reactions observed in the overall group of patients was significantly lower than the control group, the difference between the two groups was statistically significant (P<0.05). Conclusion: Compared with non-steroidal anti-inflammatory drugs, the use of methotrexate and sulfasalazine treatment of rheumatoid its more significant effect.